Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-043516
Filing Date
2020-07-23
Accepted
2020-07-23 17:27:33
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6339
  Complete submission text file 0001209191-20-043516.txt   7695
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Sonsini Peter W. (Reporting) CIK: 0001559807 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39402 | Film No.: 201044373